Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126646332 | 12664633 | 2 | F | 20160807 | 20160825 | 20160818 | 20160901 | EXP | PHHY2016TW111367 | NOVARTIS | 71.67 | YR | M | Y | 65.00000 | KG | 20160901 | MD | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126646332 | 12664633 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, QD | 22068 | 600 | MG | CAPSULE | QD | ||||||
| 126646332 | 12664633 | 2 | C | CALCITRIOL. | CALCITRIOL | 1 | Unknown | UNK UNK, BID | 0 | BID | |||||||||
| 126646332 | 12664633 | 3 | C | FLUMETHASONE PIVALATE | FLUMETHASONE PIVALATE | 1 | Unknown | UNK UNK, BID | 0 | BID | |||||||||
| 126646332 | 12664633 | 4 | C | CLOBETASOL PROPIONATE. | CLOBETASOL PROPIONATE | 1 | Unknown | UNK UNK, QD | 0 | QD | |||||||||
| 126646332 | 12664633 | 5 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 0.5 OT, QD | U | 0 | QD | ||||||||
| 126646332 | 12664633 | 6 | C | GLIMEPIRIDE W/METFORMIN | GLIMEPIRIDEMETFORMIN | 1 | Unknown | 2 MG/ 500 MG (1 TAB AM 0.5 TAB PM) | 0 | ||||||||||
| 126646332 | 12664633 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 0.5 OT, ONCE/SINGLE | U | 0 | 1X | ||||||||
| 126646332 | 12664633 | 8 | C | PITAVASTATIN | PITAVASTATIN | 1 | Unknown | 0.5 OT, QD | 0 | QD | |||||||||
| 126646332 | 12664633 | 9 | C | TAMSULOSIN | TAMSULOSIN | 1 | Unknown | 1 TAB HS | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126646332 | 12664633 | 1 | Chronic myeloid leukaemia |
| 126646332 | 12664633 | 2 | Psoriasis |
| 126646332 | 12664633 | 3 | Psoriasis |
| 126646332 | 12664633 | 4 | Psoriasis |
| 126646332 | 12664633 | 5 | Hypertensive heart disease |
| 126646332 | 12664633 | 6 | Diabetes mellitus |
| 126646332 | 12664633 | 7 | Hypertensive heart disease |
| 126646332 | 12664633 | 8 | Hyperlipidaemia |
| 126646332 | 12664633 | 9 | Benign prostatic hyperplasia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126646332 | 12664633 | HO |
| 126646332 | 12664633 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126646332 | 12664633 | Blood glucose increased | |
| 126646332 | 12664633 | Chronic obstructive pulmonary disease | |
| 126646332 | 12664633 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126646332 | 12664633 | 1 | 20140704 | 0 | ||
| 126646332 | 12664633 | 2 | 20160705 | 0 | ||
| 126646332 | 12664633 | 3 | 20160705 | 0 | ||
| 126646332 | 12664633 | 4 | 20160719 | 0 | ||
| 126646332 | 12664633 | 6 | 20160429 | 0 | ||
| 126646332 | 12664633 | 8 | 20160729 | 0 | ||
| 126646332 | 12664633 | 9 | 20150429 | 0 |